Regulation of corticotropin-releasing hormone in vitro

Studies examining regulation of corticotropin-releasing hormone (CRH) in vitro have been used to validate findings obtained in vivo and more importantly have been used as model systems to better understand signalling mechanisms responsible for the expression of the CRH gene and peptide. Most in vitro studies examining CRH have utilized hypothalamic tissue while a few have focused on the amygdala. Furthermore, clonal cell lines have also been utilized as models of central nervous system CRH neurons. Stimuli that have been implicated in regulating hypothalamic CRH in vitro include protein kinase A (PKA) and protein kinase C (PKC) activators, glucocorticoids, biogenic amines, cytokines and the gaseous neurotransmitters. CRH levels in the amygdala in vitro are affected by some of the same stimuli that regulate hypothalamic CRH; however there is evidence supporting differential regulation of CRH in these two brain regions by some of the same stimuli. Only a few studies in aggregate have investigated the signal transduction mechanisms responsible for CRH expression. These mechanistic studies have focused on PKA- and glucocorticoid-mediated changes in CRH expression. Clearly much more investigative work in better understanding CRH regulation in vitro is needed.

[1]  S. Reichlin,et al.  Acetylcholine stimulates the secretion of corticotropin-releasing factor from primary dissociated cell cultures of the rat telencephalon and diencephalon , 1990, Brain Research.

[2]  P. Sawchenko,et al.  Distribution of corticotropin-releasing factor mRNA and immunoreactivity in the central auditory system of the rat , 1991, Brain Research.

[3]  S. Lightman,et al.  Interleukin-1β induces corticotropin-releasing factor-41 release from cultured hypothalamic cells through protein kinase C and cAMP-dependent protein kinase pathways , 1992, Journal of Neuroimmunology.

[4]  G. Chrousos,et al.  Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. , 1988, Neuroendocrinology.

[5]  J. Majzoub,et al.  Second messengers involved in the regulation of corticotropin-releasing hormone mRNA and peptide in cultured rat fetal hypothalamic primary cultures. , 1990, Endocrinology.

[6]  G. Adler,et al.  Protein kinase-C activation increases the quantity and poly(A) tail length of corticotropin-releasing hormone messenger RNA in NPLC cells. , 1992, Molecular endocrinology.

[7]  I. Clarke,et al.  Evidence that the central noradrenergic and adrenergic pathways activate the hypothalamic-pituitary-adrenal axis in the sheep. , 1991, Endocrinology.

[8]  J. Herman,et al.  Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. , 1996, Critical reviews in neurobiology.

[9]  B. McEwen,et al.  Stress and the individual. Mechanisms leading to disease. , 1993, Archives of internal medicine.

[10]  E. Stark,et al.  Effects of gamma-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release. , 1974, Neuroendocrinology.

[11]  J. Vaughan,et al.  Characterization and regulation of corticotropin-releasing factor in the human hepatoma NPLC-KC cell line. , 1993, Neuroendocrinology.

[12]  R. Thompson,et al.  Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression. , 1987, Molecular endocrinology.

[13]  K. Lyson,et al.  Alpha-melanocyte-stimulating hormone abolishes IL-1- and IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro. , 1993, Neuroendocrinology.

[14]  F. Bloom,et al.  Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. , 1995, The Journal of pharmacology and experimental therapeutics.

[15]  J. Borrell,et al.  Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids. , 1992, Endocrinology.

[16]  N. Swerdlow,et al.  Behavioral activation by CRF: evidence for the involvement of the ventral forebrain. , 1987, Life sciences.

[17]  J. Kasckow,et al.  Interleukin-1 regulation of corticotropin-releasing factor (CRF), glucocorticoid receptor, c-fos and c-jun messenger RNA in the NPLC-KC cell line , 1998, Molecular and Cellular Endocrinology.

[18]  A. Seasholtz,et al.  The cAMP-responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization. , 1994, The Journal of biological chemistry.

[19]  R. Gibaud,et al.  Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat. , 1987, Endocrinology.

[20]  T. Suda,et al.  Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro , 1986, Brain Research.

[21]  T. Suda,et al.  Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. , 1991, Endocrinology.

[22]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[23]  S. Matta,et al.  Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat. , 1988, Endocrinology.

[24]  S. Malkoski,et al.  Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene , 1997, Molecular and Cellular Endocrinology.

[25]  B. McEwen,et al.  Re-examination of the glucocorticoid hypothesis of stress and aging. , 1992, Progress in brain research.

[26]  B. McEwen,et al.  The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. , 1986, Endocrine reviews.

[27]  C. Rivier,et al.  Nitric Oxide Stimulates ACTH Secretion and the Transcription of the Genes Encoding for NGFI-B, Corticotropin-Releasing Factor, Corticotropin-Releasing Factor Receptor Type 1, and Vasopressin in the Hypothalamus of the Intact Rat , 1999, The Journal of Neuroscience.

[28]  G. Koob,et al.  Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action , 1992, Brain Research.

[29]  C. Nemeroff,et al.  Interleukin‐1α induces corticotropin‐releasing factor secretion and synthesis from NPLC‐KC cells through various second messenger pathways , 1994, Synapse.

[30]  T. Suda,et al.  Inhibitory effect of norepinephrine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. , 1987, Life sciences.

[31]  G. Koob,et al.  Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  S. Camper,et al.  Nucleotide sequence and expression of the mouse corticotropin-releasing hormone gene , 1991, Molecular and Cellular Neuroscience.

[33]  I. Heuser,et al.  The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. , 1992, Progress in brain research.

[34]  G. Adler,et al.  Expression and dexamethasone regulation of the human corticotropin-releasing hormone gene in a mouse anterior pituitary cell line. , 1988, The Journal of biological chemistry.

[35]  J. Schulkin,et al.  Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus , 1994, Brain Research.

[36]  N. Porter,et al.  Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis. , 1992, Journal of neurobiology.

[37]  R. Sapolsky The neuroendocrinology of stress and aging , 1984 .

[38]  W. Vale,et al.  Characterization of rat hypothalamic corticotropin-releasing factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Thompson,et al.  Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. , 1988, Molecular endocrinology.

[40]  F. Holsboer,et al.  Glucocorticoid repression of 3',5'-cyclic-adenosine monophosphate-dependent human corticotropin-releasing-hormone gene promoter activity in a transfected mouse anterior pituitary cell line. , 1990, Endocrinology.

[41]  S. Shibahara,et al.  Isolation and sequence analysis of the human corticotropin‐releasing factor precursor gene. , 1983, The EMBO journal.

[42]  J. Kasckow,et al.  Coordinate and Divergent Regulation of Corticotropin-Releasing Factor (CRF) and CRF-Binding Protein Expression in an Immortalized Amygdalar Neuronal Cell Line* *Portions of this report were presented in abstract form at the 1997 and 1998 annual meetings of The Endocrine Society. , 1999, Endocrinology.

[43]  D. Birkle,et al.  Depolarization-induced release of corticotropin-releasing factor (CRF) in primary neuronal cultures of the amygdala , 1994, Neuropeptides.

[44]  R. Knight,et al.  Action of interleukin-2 and interleukin-4 on CRF mRNA in the hypothalamus and POMC mRNA in the anterior pituitary , 1992, Brain, Behavior, and Immunity.

[45]  T. Suda,et al.  Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. , 1994, Endocrinology.

[46]  S. Lightman,et al.  Release of corticotrophin-releasing factor-41, arginine vasopressin and oxytocin from rat fetal hypothalamic cells in culture: response to activation of intracellular second messengers and to corticosteroids. , 1992, The Journal of endocrinology.

[47]  T. Suda,et al.  In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus. , 1985, Life sciences.

[48]  A. Grossman,et al.  Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro , 1993, Brain Research.

[49]  A. Grossman,et al.  Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. , 1991, Endocrinology.

[50]  P. J. Larsen,et al.  Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress. , 1995, Life sciences.

[51]  K. Lyson,et al.  Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  L. Swanson,et al.  Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: I. cytoarchitecture , 1989, The Journal of comparative neurology.

[53]  R. Kathol,et al.  Pathophysiology of HPA axis abnormalities in patients with major depression: an update. , 1989, The American journal of psychiatry.

[54]  M. Jones,et al.  The effect of various putative neurotransmitters on the release of corticotrophin releasing hormone from the hypothalamus of the rat in vitro. I. The effect of acetylcholine and noradrenaline. , 1975, Neuroendocrinology.

[55]  D. Price,et al.  Corticotropin-releasing factor mRNA is expressed in the inferior olives of rodents and primates. , 1986, Brain research.

[56]  A. Grossman,et al.  The regulation of hypothalamic corticotropin-releasing factor release: in vitro studies. , 1993, Ciba Foundation symposium.

[57]  D. Birkle,et al.  N-methyl-d-aspartate (NMDA)-mediated corticotropin-releasing factor (CRF) release in cultured rat amygdala neurons1 1 Abbreviations used: CRF, corticotropin-releasing factor; NMDA, N-methyl-d-aspartate; AP-5, 2-amino-5-phosphonovaleric acid; LC, locus coeruleus; DIC, days in culture. , 1999, Peptides.

[58]  D. Parkes,et al.  Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: studies in primary amygdalar cultures. , 1997, Endocrinology.

[59]  N. Milton,et al.  Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. , 1989, The Journal of endocrinology.

[60]  R. Sapolsky,et al.  Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. , 1987, Science.

[61]  E. Widmaier,et al.  Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: effects of catecholamines. , 1989, Endocrinology.

[62]  Kazuhiro Takahashi,et al.  Suppression by glucocorticoid of the immunoreactivity of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus , 1987, Neuroscience Letters.

[63]  L. P. Van Phorbolester stimulates the activity of human corticotropin-releasing hormone gene promoter via 3',5'-cyclic adenosine monophosphate response element in transiently transfected chicken macrophages. , 1993, Endocrinology.

[64]  L. H. Gates,et al.  Negative glucorticoid regulation of cyclic adenosine 3', 5'-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells. , 1996, Molecular endocrinology.

[65]  G. Chrousos,et al.  Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. , 1997, Neuroimmunomodulation.

[66]  H. Imura,et al.  Regulation of human corticotropin-releasing hormone gene expression by 3',5'-cyclic adenosine monophosphate in a transformed mouse corticotroph cell line. , 1989, Molecular endocrinology.

[67]  A. Grossman,et al.  Carbon monoxide as a novel neuroendocrine modulator: inhibition of stimulated corticotropin-releasing hormone release from acute rat hypothalamic explants. , 1994, Endocrinology.

[68]  P. Plotsky Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. , 1987, Endocrinology.

[69]  M. Davis,et al.  Anatomic and physiologic substrates of emotion in an animal model. , 1998, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[70]  E. O. Johnson,et al.  The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. , 1989, Endocrinology.

[71]  J. Dimicco,et al.  Effect of microinjection of muscimol into the dorsomedial or paraventricular hypothalamic nucleus on air stress-induced neuroendocrine and cardiovascular changes in rats , 1996, Brain Research.

[72]  J. Spiess,et al.  Immortalization of a fetal rat brain cell line that expresses corticotropin-releasing factor mRNA. , 1993, DNA and cell biology.

[73]  S. Rivest,et al.  Interleukin-6 Is a Needed Proinflammatory Cytokine in the Prolonged Neural Activity and Transcriptional Activation of Corticotropin-Releasing Factor during Endotoxemia1. , 1999, Endocrinology.

[74]  M. Palkovits,et al.  Time dependent changes in CRF and its mRNA in the neurons of the inferior olive following surgical transection of the olivocerebellar tract in the rat. , 1991, Brain research. Molecular brain research.

[75]  G. Chrousos,et al.  Structural analysis of the regulatory region of the human corticotropin releasing hormone gene , 1990, FEBS letters.

[76]  J. Herman,et al.  Differential expression of corticotropin-releasing hormone in developing mouse embryos and adult brain. , 1994, Endocrinology.

[77]  C. Rivier,et al.  Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats. , 2000, Endocrinology.

[78]  P. G. Smelik,et al.  Corticotropin Release: Inhibition by Intrahypothalamic Implantation of Atropine , 1968, Science.

[79]  S. Cummings,et al.  Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[80]  T. Suda,et al.  Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. , 1993, Brain research. Molecular brain research.

[81]  T. Suda,et al.  Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. , 1990, Endocrinology.

[82]  S. Southwick,et al.  Psychobiologic mechanisms of posttraumatic stress disorder. , 1993, Archives of general psychiatry.

[83]  S. Watson,et al.  Rapid regulation of corticotropin-releasing hormone gene transcription in vivo. , 1992, Molecular endocrinology.

[84]  J. Buckingham,et al.  Hypothalamic receptors influencing the secretion of corticotrophin releasing hormone in the rat , 1979, The Journal of physiology.

[85]  G. Rondouin,et al.  Removal of adrenal steroids from the medium reverses the stimulating effect of catecholamines on corticotropin-releasing hormone neurons in organotypic cultures. , 1995, Neuroendocrinology.

[86]  H. Imura,et al.  Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. , 1985, Endocrinology.

[87]  T. Suda,et al.  Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. , 1995, Endocrinology.

[88]  W. Vale,et al.  Carbon monoxide modulates secretion of corticotropin-releasing factor from rat hypothalamic cell cultures , 1994, Brain Research.

[89]  F. Holsboer,et al.  Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. , 1992, Molecular endocrinology.

[90]  L. Swanson,et al.  Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat , 1989, The Journal of comparative neurology.

[91]  A. Grossman,et al.  Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. , 1988, Endocrinology.

[92]  C. Nemeroff,et al.  Regulation of Corticotropin‐Releasing Factor Secretion and Synthesis in the Human Neuroblastoma Clones‐ BE(2)‐M17 and BE(2)‐C , 1995, Journal of neuroendocrinology.

[93]  N. Kalin,et al.  Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus , 1994, Brain Research.

[94]  J. Koolhaas,et al.  Involvement of hypothalamic serotonin in activation of the sympathoadrenomedullary system and hypothalamo-pituitary-adrenocortical axis in male Wistar rats. , 1991, European journal of pharmacology.

[95]  A. Arimura,et al.  Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. , 1987, Endocrinology.

[96]  S. Leibowitz,et al.  Norepinephrine in the paraventricular nucleus stimulates corticosterone release , 1989, Brain Research.

[97]  J. Vaughan,et al.  [38] Assay of corticotropin releasing factor , 1983 .

[98]  R. Knight,et al.  Interleukin-6 and corticotrophin-releasing hormone mRNA are modulated during differentiation of human neuroblastoma cells , 1992, Neuropeptides.